#PrEP

Traditionally hep C transmits sexually mostly among HIV-positive men who have sex with men.

Researchers believe that hepatitis C is spreading through sex from the HIV-positive population to those who don’t have HIV.

For over 30 years, the California-based group fought for treatments, research, education and quality health care.

Nevertheless, researchers advise careful kidney monitoring when pairing the medications.

A speedy overview of the major scientific findings presented at the International AIDS Conference in Amsterdam (AIDS 2018)

Highlights from HIV and hepatitis C research presented at the 2018 Conference on Retroviruses and Opportunistic Infections (CROI) in Boston

Another initiative of the Elton John AIDS Foundation will focus on HIV and hep C in Eastern Europe and Central Asia.

The rebranding reflects expanded services, including a medical clinic and a focus on STIs and hepatitis.

The World Health Organization (WHO) has added a new hepatitis C treatment to its updated 2017 Essential Medicines List.

Highlights from the research presented at the 9th International AIDS Society Conference on HIV Science in Paris.

The update includes a new combination therapy that can treat all six genotypes of HCV, a new HIV medication and PrEP.

In Houston, some pharmacies will also begin prescribing Truvada as PrEP on-site.

A look at the most notable HIV-related studies presented at the 2017 Conference on Retroviruses and Opportunistic Infections in Seattle.

No doubt PrEP prevents HIV/AIDS but it is also surely a catalyst for cases of Hep-C to skyrocket in MSM.

Could hep C medications be used to prevent infection in the first place?

A study of European men who have sex with men found that nearly one in three were reinfected within five years.